FilingSEC EDGARPOS AM
Nasus Pharma Files Post-Effective Amendment for Resale of Private Placement Securities
· SEC accepted
StageRegistration
Filing content
The company filed a post-effective amendment to register the resale of ordinary shares and warrants issued in a February 2026 private placement.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…